The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
Given that vascular changes are an early preclinical feature of Alzheimer's disease pathology, with changes beginning years to decades prior to symptoms, the hope is that rejuvenative factors in young blood may one day be produced at scale and used to treat vascular dementia & Alzheimer's disease.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
it has been shown like 20 30 years ago and um but people didn't really pay attention to that vascular phenotype that we were seeing on postpartum rate it's just I I would say probably the last 10 years or so that we are really uh um tackling this because we have more and more evidence that shows that the vascular dysfunction and we can go into details a bit later but the the brain vessels so the blood vessels starts to be dysfunctional and leaky